annual shareholders equity:
$3.46B-$135.38M(-3.76%)Summary
- As of today (May 31, 2025), CRL annual stockholders equity is $3.46 billion, with the most recent change of -$135.38 million (-3.76%) on December 28, 2024.
- During the last 3 years, CRL annual shareholders equity has risen by +$926.68 million (+36.56%).
- CRL annual shareholders equity is now -3.76% below its all-time high of $3.60 billion, reached on December 30, 2023.
Performance
CRL Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$3.19B-$267.17M(-7.72%)Summary
- As of today (May 31, 2025), CRL quarterly stockholders equity is $3.19 billion, with the most recent change of -$267.17 million (-7.72%) on March 29, 2025.
- Over the past year, CRL quarterly shareholders equity has dropped by -$446.10 million (-12.25%).
- CRL quarterly shareholders equity is now -15.54% below its all-time high of $3.78 billion, reached on September 28, 2024.
Performance
CRL quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CRL Shareholders equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -3.8% | -12.3% |
3 y3 years | +36.6% | +22.4% |
5 y5 years | +111.8% | +93.4% |
CRL Shareholders equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -3.8% | +36.6% | -15.5% | +22.4% |
5 y | 5-year | -3.8% | +111.8% | -15.5% | +93.4% |
alltime | all time | -3.8% | +3242.8% | -15.5% | +2973.3% |
CRL Shareholders equity History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $3.19B(-7.7%) |
Dec 2024 | $3.46B(-3.8%) | $3.46B(-8.5%) |
Sep 2024 | - | $3.78B(+1.6%) |
Jun 2024 | - | $3.72B(+2.3%) |
Mar 2024 | - | $3.64B(+1.2%) |
Dec 2023 | $3.60B(+20.9%) | $3.60B(+8.8%) |
Sep 2023 | - | $3.31B(+1.7%) |
Jun 2023 | - | $3.25B(+4.6%) |
Mar 2023 | - | $3.11B(+4.4%) |
Dec 2022 | $2.98B(+17.4%) | $2.98B(+13.3%) |
Sep 2022 | - | $2.63B(-0.8%) |
Jun 2022 | - | $2.65B(+1.4%) |
Mar 2022 | - | $2.61B(+3.0%) |
Dec 2021 | $2.53B(+19.9%) | $2.53B(+4.5%) |
Sep 2021 | - | $2.43B(+4.7%) |
Jun 2021 | - | $2.32B(+6.2%) |
Mar 2021 | - | $2.18B(+3.3%) |
Dec 2020 | $2.11B(+29.4%) | $2.11B(+11.5%) |
Sep 2020 | - | $1.90B(+8.2%) |
Jun 2020 | - | $1.75B(+6.1%) |
Mar 2020 | - | $1.65B(+1.1%) |
Dec 2019 | $1.63B(+24.1%) | $1.63B(+6.7%) |
Sep 2019 | - | $1.53B(+5.3%) |
Jun 2019 | - | $1.46B(+4.1%) |
Mar 2019 | - | $1.40B(+6.1%) |
Dec 2018 | $1.32B(+26.1%) | $1.32B(+5.1%) |
Sep 2018 | - | $1.25B(+6.0%) |
Jun 2018 | - | $1.18B(+3.7%) |
Mar 2018 | - | $1.14B(+9.1%) |
Dec 2017 | $1.05B(+24.9%) | $1.05B(+2.3%) |
Sep 2017 | - | $1.02B(+6.0%) |
Jun 2017 | - | $963.50M(+9.9%) |
Mar 2017 | - | $876.43M(+4.7%) |
Dec 2016 | $836.77M(+14.1%) | $836.77M(-3.6%) |
Sep 2016 | - | $867.97M(+4.4%) |
Jun 2016 | - | $831.35M(+6.6%) |
Mar 2016 | - | $779.82M(+6.4%) |
Dec 2015 | $733.07M(+9.1%) | $733.07M(+4.1%) |
Sep 2015 | - | $704.36M(+0.4%) |
Jun 2015 | - | $701.70M(+5.7%) |
Mar 2015 | - | $663.71M(-1.3%) |
Dec 2014 | $672.20M(+4.9%) | $672.20M(+0.3%) |
Sep 2014 | - | $670.30M(-0.2%) |
Jun 2014 | - | $671.82M(-3.4%) |
Mar 2014 | - | $695.46M(+8.5%) |
Dec 2013 | $640.98M(+6.7%) | $640.98M(-2.4%) |
Sep 2013 | - | $656.51M(+1.3%) |
Jun 2013 | - | $647.95M(+3.1%) |
Mar 2013 | - | $628.28M(+4.6%) |
Dec 2012 | $600.80M | $600.80M(+0.5%) |
Sep 2012 | - | $597.71M(+6.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2012 | - | $562.84M(+1.9%) |
Mar 2012 | - | $552.60M(+5.1%) |
Dec 2011 | $525.58M(-23.5%) | $525.58M(-2.6%) |
Sep 2011 | - | $539.71M(-8.4%) |
Jun 2011 | - | $589.09M(+4.6%) |
Mar 2011 | - | $562.92M(-18.1%) |
Dec 2010 | $687.42M(-50.0%) | $687.42M(-34.0%) |
Sep 2010 | - | $1.04B(-25.5%) |
Jun 2010 | - | $1.40B(+0.8%) |
Mar 2010 | - | $1.39B(+0.8%) |
Dec 2009 | $1.38B(+14.7%) | $1.38B(+1.9%) |
Sep 2009 | - | $1.35B(+5.2%) |
Jun 2009 | - | $1.28B(+5.4%) |
Mar 2009 | - | $1.22B(+1.6%) |
Dec 2008 | $1.20B(-35.6%) | $1.20B(-38.4%) |
Sep 2008 | - | $1.95B(+0.1%) |
Jun 2008 | - | $1.95B(+1.9%) |
Mar 2008 | - | $1.91B(+2.7%) |
Dec 2007 | $1.86B(+16.6%) | $1.86B(+3.2%) |
Sep 2007 | - | $1.80B(+4.2%) |
Jun 2007 | - | $1.73B(+5.3%) |
Mar 2007 | - | $1.64B(+2.9%) |
Dec 2006 | $1.60B(-12.7%) | $1.60B(+2.7%) |
Sep 2006 | - | $1.55B(-5.3%) |
Jun 2006 | - | $1.64B(-5.5%) |
Mar 2006 | - | $1.74B(-4.9%) |
Dec 2005 | $1.83B(+24.1%) | $1.83B(+2.3%) |
Sep 2005 | - | $1.79B(+3.1%) |
Jun 2005 | - | $1.73B(+14.1%) |
Mar 2005 | - | $1.52B(+3.1%) |
Dec 2004 | $1.47B(+216.9%) | $1.47B(+167.3%) |
Sep 2004 | - | $550.82M(+6.1%) |
Jun 2004 | - | $519.06M(+5.1%) |
Mar 2004 | - | $494.00M(+6.3%) |
Dec 2003 | $464.62M(+30.0%) | $464.62M(+7.6%) |
Sep 2003 | - | $431.94M(+4.9%) |
Jun 2003 | - | $411.70M(+8.2%) |
Mar 2003 | - | $380.35M(+6.4%) |
Dec 2002 | $357.38M(+23.4%) | $357.38M(+7.4%) |
Sep 2002 | - | $332.84M(+7.5%) |
Jun 2002 | - | $309.54M(+7.3%) |
Mar 2002 | - | $288.41M(-0.4%) |
Dec 2001 | $289.51M(+141.5%) | $289.51M(+4.3%) |
Sep 2001 | - | $277.67M(+33.4%) |
Jun 2001 | - | $208.22M(+4.6%) |
Mar 2001 | - | $199.14M(+66.1%) |
Dec 2000 | $119.86M(-208.8%) | $119.86M(+6.0%) |
Sep 2000 | - | $113.09M(-204.1%) |
Jun 2000 | - | -$108.66M(-2.3%) |
Mar 2000 | - | -$111.17M |
Dec 1999 | -$110.14M(-165.5%) | - |
Dec 1998 | $168.26M | - |
FAQ
- What is Charles River Laboratories International annual stockholders equity?
- What is the all time high annual shareholders equity for Charles River Laboratories International?
- What is Charles River Laboratories International annual shareholders equity year-on-year change?
- What is Charles River Laboratories International quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly shareholders equity year-on-year change?
What is Charles River Laboratories International annual stockholders equity?
The current annual shareholders equity of CRL is $3.46B
What is the all time high annual shareholders equity for Charles River Laboratories International?
Charles River Laboratories International all-time high annual stockholders equity is $3.60B
What is Charles River Laboratories International annual shareholders equity year-on-year change?
Over the past year, CRL annual stockholders equity has changed by -$135.38M (-3.76%)
What is Charles River Laboratories International quarterly stockholders equity?
The current quarterly shareholders equity of CRL is $3.19B
What is the all time high quarterly shareholders equity for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly stockholders equity is $3.78B
What is Charles River Laboratories International quarterly shareholders equity year-on-year change?
Over the past year, CRL quarterly stockholders equity has changed by -$446.10M (-12.25%)